U.S. Animal Biotechnology Market Size & Outlook, 2022-2030
U.S. animal biotechnology market, 2018-2030 (US$M)
U.S. animal biotechnology market highlights
- The U.S. animal biotechnology market generated a revenue of USD 5,639.7 million in 2022 and is expected to reach USD 10,626.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.2% from 2023 to 2030.
- In terms of segment, vaccines was the largest revenue generating product in 2022.
- Diagnostics Tests is the most lucrative product segment registering the fastest growth during the forecast period.
Animal biotechnology market data book summary
| Market revenue in 2022 | USD 5,639.7 million |
| Market revenue in 2030 | USD 10,626.0 million |
| Growth rate | 8.2% (CAGR from 2022 to 2030) |
| Largest segment | Vaccines |
| Fastest growing segment | Diagnostics Tests |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics Tests, Vaccines, Drugs, Reproductive And Genetic, Feed Additives |
| Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Biogenesis Bago, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Hester Biosciences, Kareo, NXGN |
Other key industry trends
- In terms of revenue, U.S. accounted for 23.3% of the global animal biotechnology market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. animal biotechnology market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 2,858.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Animal Biotechnology Market Scope
Animal Biotechnology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. animal biotechnology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal biotechnology market will help companies and investors design strategic landscapes.
Vaccines was the largest segment with a revenue share of 23.16% in 2022. Horizon Databook has segmented the U.S. animal biotechnology market based on diagnostics tests, vaccines, drugs, reproductive and genetic, feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. animal biotechnology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. animal biotechnology market databook
-
Our clientele includes a mix of animal biotechnology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. animal biotechnology market, including forecasts for subscribers. This country databook contains high-level insights into U.S. animal biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. animal biotechnology market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
